ArticleCardiovascular diabetology2026
Assessment of seven insulin resistance surrogate indexes for predicting cardiometabolic multimorbidity among Chinese middle-aged and older adults: a national prospective cohort study.
Article in Cardiovascular diabetology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCardiometabolic multimorbidity (CMM) poses a mounting health challenge worldwide. Seven surrogate indexes of insulin resistance (IR)-the triglyceride-glucose index (TyG), TyG-body mass index (TyG-BMI), TyG-waist circumference (TyG-WC), Chinese visceral adiposity Index (CVAI), Metabolic score for IR (METS-IR), Atherogenic index of plasma (AIP), and estimated glucose disposal rate (eGDR)-are well-established. However, comparative studies evaluating their predictive capacity for CMM incidence in Chinese middle-aged and older adults remain scarce. This study aimed to assess the associations between these seven IR indexes and CMM risk within this population and determine their relative predictive abilities.
methodsUtilizing the China Health and Retirement Longitudinal Study (CHARLS) 2011-2020 datasets, this prospective cohort investigation assessed Chinese participants aged ≥ 45 years. We applied Kaplan-Meier curve plotting, multivariable Cox proportional hazards models, and restricted cubic splines (RCS) to quantify associations of insulin resistance surrogate indexes with CMM risk. Predictive accuracy was appraised via time-dependent receiver operating characteristic (ROC) curves, net reclassification improvement (NRI), and integrated discrimination improvement (IDI). Subgroup evaluations further verified findings robustness.
resultsDuring a median follow-up of 9 years, 1043 (14.49%) of the 7197 participants developed CMM. After adjusting for potential confounders, we observed that each standard deviation (SD) increase in eGDR was associated with a reduced risk of CMM, with an adjusted hazard ratio (HR) of 0.834 [95% confidence interval (CI): 0.781-0.891]. In contrast, each SD increase in TyG, TyG-BMI, TyG-WC, METS-IR, AIP and CVAI were associated with an increased risk of CMM. Restricted cubic spline analyses showed that TyG-BMI, TyG-WC, METS-IR, and eGDR were nonlinear associated with incident new-onset CMM (P-nonlinearity < 0.05). eGDR showed a L-shaped association (P-nonlinearity < 0.05), with CMM risk decreasing until the inflection point at 11.82 (HR = 0.758; 95% CI: 0.702-0.818). Conversely, TyG-WC displayed a U-shaped relationship (inflection point: 572.14). Moreover, the time-dependent AUC analysis revealed that eGDR exhibited superior predictive discrimination (AUC 0.68-0.76) during early follow-up and across all intervals. The optimal cut-off value for eGDR was determined to be 7.64.
conclusionAll seven insulin resistance surrogate indexes independently demonstrated elevated CMM risk. In the context of Chinese middle-aged and elderly cohorts, eGDR demonstrated a notable predictive capacity for CMM. ROC-derived cut-offs (eGDR < 7.64) are utilised for identifying high-risk individuals requiring intervention. Spline-derived thresholds (eGDR = 11.82) serve as therapeutic targets for risk reduction.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.